<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04616495</url>
  </required_header>
  <id_info>
    <org_study_id>TRASMETIR</org_study_id>
    <nct_id>NCT04616495</nct_id>
  </id_info>
  <brief_title>Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases</brief_title>
  <acronym>TRASMETIR</acronym>
  <official_title>Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario La Fe</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicentric prospective and observational study to assess the 5-year overall survival in a&#xD;
      cohort of patients with unresectable liver-only colorectal metastases, well controlled by&#xD;
      chemotherapy prior to liver transplantation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">September 2028</completion_date>
  <primary_completion_date type="Anticipated">September 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>five year overall survival (OS)</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>one year disease free survival (DFS)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>three year disease free survival (DFS)</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>five year disease free survival (DFS)</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life using EORTC questionnaires: QLQ-C30</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life using EORTC questionnaires: QLQ-C30</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life using EORTC questionnaires: QLQ-C30</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Metastatic Liver Cancer</condition>
  <condition>Liver Metastases</condition>
  <arm_group>
    <arm_group_label>Liver transplanted patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Liver transplantation</intervention_name>
    <description>Chemotherapy and liver transplantation</description>
    <arm_group_label>Liver transplanted patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort of patients detected in oncological units where they have been treated for&#xD;
        colorectal cancer (stage IV with liver only unresectable metastases)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 and ≤ years&#xD;
&#xD;
          -  Good performance status, ECOG 0 or 1&#xD;
&#xD;
          -  Resected adenocarcinoma in colon or rectum (R0 resection)&#xD;
&#xD;
          -  Unresectable liver metastases&#xD;
&#xD;
          -  No extrahepatic disease&#xD;
&#xD;
          -  Normal blood tests&#xD;
&#xD;
          -  Response to ≤ 2 lines of chemotherapy (RECIST criteria)&#xD;
&#xD;
          -  ≥ 1 year period since diagnosis of colorectal cancer to enrolment in liver transplant&#xD;
             waiting list&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body mass index ≥ 30&#xD;
&#xD;
          -  Positive HIV or HCV&#xD;
&#xD;
          -  Pregnancy at the time of inclusion&#xD;
&#xD;
          -  BRAF mutated status&#xD;
&#xD;
          -  Deterioration of general condition (10% weight loss in the prior 6 months)&#xD;
&#xD;
          -  Other malignancy with disease free survival &lt; 5 years&#xD;
&#xD;
          -  Concomitant or prior extrahepatic metastases (histologically or radiologically&#xD;
             proved), even if surgically resected.&#xD;
&#xD;
          -  Palliative resection of primary colorectal adenocarcinoma&#xD;
&#xD;
          -  Liver metastases size &gt; 5 cm (in the last imaging technique)&#xD;
&#xD;
          -  CEA &gt; 80 ng/ml (at time of enrolment in waiting list)&#xD;
&#xD;
          -  No neoadjuvant chemotherapy treatment&#xD;
&#xD;
          -  General contraindication to liver transplantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Eva M Montalvá, PhD</last_name>
    <phone>+34961245858</phone>
    <email>montalva.oron@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eva M Montalvá</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva M Montalvá, PhD</last_name>
      <phone>+34961245858</phone>
      <email>montalva.oron@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 25, 2020</study_first_submitted>
  <study_first_submitted_qc>November 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario La Fe</investigator_affiliation>
    <investigator_full_name>Eva M. Montalvá</investigator_full_name>
    <investigator_title>Hepatobiliarypancreatic and Transplant Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

